T

T2 Biosystems

TTOO

4.99000
USD
0.16
(3.31%)
Market Closed
Volume
30,950
EPS
0
Div Yield
0
P/E
0
Market Cap
26,779,290
Related Instruments
ABT
4.220
(3.98%)
110.150 USD
A
AYTU
-0.05000
(-1.89%)
2.60000 USD
B
BNGO
-0.05270
(-8.23%)
0.58760 USD
C
CODX
-0.03000
(-2.59%)
1.13000 USD
E
EXAS
12.150
(26.55%)
57.910 USD
O
OPK
-0.05000
(-3.50%)
1.38000 USD
T
TDOC
-0.85000
(-9.00%)
8.59000 USD
V
VCEL
-2.900
(-5.72%)
47.800 USD
V
VXRT
-0.01170
(-1.74%)
0.65890 USD
News

Title: T2 Biosystems

Sector: Healthcare
Industry: Diagnostics & Research
T2 Biosystems Inc is a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes. It is dedicated to improving patient care and reducing the cost of care by helping clinicians effectively treat patients faster than ever before. The company's products include the T2Dx Instrument, the T2Bacteria Panel, the T2Candida Panel, the T2Resistance Panel, and the T2Biothreat Panel, and are powered by the proprietary T2 Magnetic Resonance technology.